Search

Author/Creator Melega, Simone

2. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Issue 1 (5th December 2021)

Authors:
Brogan, Paul; Yeung, Rae S. M.; Cleary, Gavin; Rangaraj, Satyapal; Kasapcopur, Ozgur; Hersh, Aimee O.; Li, Suzanne; Paripovic, Dusan; Schikler, Kenneth; Zeft, Andrew; Bracaglia, Claudia; Eleftheriou, Despina; Pordeli, Pooneh; Melega, Simone; Jamois, Candice; Gaudreault, Jacques; Michalska, Margar...
Journal:
Arthritis & rheumatology
Issue:
Volume 74:Issue 1(2022)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis. Issue 9 (28th June 2022)

Authors:
Jamois, Candice; Gibiansky, Leonid; Chavanne, Clarisse; Cheu, Melissa; Lehane, Patricia B.; Pordeli, Pooneh; Melega, Simone; Gaudreault, Jacques
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 9(2022)
Page Start:
2172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rituximab utilization for approved and off‐label nononcology indications and patients' experiences with the Patient Alert Card. Issue 1 (3rd January 2020)

Authors:
Sarsour, Khaled; Beckley‐Kartey, Senam; Melega, Simone; Odueyungbo, Adefowope; Kirchner, Petra; Khalife, Natasha; Bangs, Joanne
Journal:
Pharmacology research & perspectives
Issue:
Volume 8:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗